Logo image of TWST

TWIST BIOSCIENCE CORP (TWST) Stock Price, Quote, News and Overview

NASDAQ:TWST - Nasdaq - US90184D1000 - Common Stock - Currency: USD

25.64  +0.64 (+2.56%)

After market: 26 +0.36 (+1.4%)

TWST Quote, Performance and Key Statistics

TWIST BIOSCIENCE CORP

NASDAQ:TWST (8/8/2025, 8:10:08 PM)

After market: 26 +0.36 (+1.4%)

25.64

+0.64 (+2.56%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High55.33
52 Week Low24.28
Market Cap1.54B
Shares59.92M
Float58.74M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)11-17 2025-11-17/amc
IPO10-31 2018-10-31


TWST short term performance overview.The bars show the price performance of TWST in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

TWST long term performance overview.The bars show the price performance of TWST in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 -20 -30 -40

The current stock price of TWST is 25.64 USD. In the past month the price decreased by -32.58%. In the past year, price decreased by -41.69%.

TWIST BIOSCIENCE CORP / TWST Daily stock chart

TWST Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.7 349.84B
AMGN AMGEN INC 13.22 154.98B
GILD GILEAD SCIENCES INC 15.43 148.54B
VRTX VERTEX PHARMACEUTICALS INC 21.64 94.13B
REGN REGENERON PHARMACEUTICALS 12.34 60.79B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 57.23B
ARGX ARGENX SE - ADR 71.39 40.50B
ONC BEONE MEDICINES LTD-ADR 4.5 31.19B
BNTX BIONTECH SE-ADR N/A 26.84B
SMMT SUMMIT THERAPEUTICS INC N/A 21.28B
INSM INSMED INC N/A 20.78B
NTRA NATERA INC N/A 20.75B

About TWST

Company Profile

TWST logo image Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 923 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The firm leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The firm also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The company is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. The company makes products for use across many industries, including healthcare, industrial chemicals, agriculture and academic research.

Company Info

TWIST BIOSCIENCE CORP

681 Gateway Blvd.

South San Francisco CALIFORNIA 94080 US

CEO: Emily M. Leproust

Employees: 923

TWST Company Website

TWST Investor Relations

Phone: 18007190671

TWIST BIOSCIENCE CORP / TWST FAQ

What is the stock price of TWIST BIOSCIENCE CORP today?

The current stock price of TWST is 25.64 USD. The price increased by 2.56% in the last trading session.


What is the ticker symbol for TWIST BIOSCIENCE CORP stock?

The exchange symbol of TWIST BIOSCIENCE CORP is TWST and it is listed on the Nasdaq exchange.


On which exchange is TWST stock listed?

TWST stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for TWIST BIOSCIENCE CORP stock?

18 analysts have analysed TWST and the average price target is 48.77 USD. This implies a price increase of 90.22% is expected in the next year compared to the current price of 25.64. Check the TWIST BIOSCIENCE CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is TWIST BIOSCIENCE CORP worth?

TWIST BIOSCIENCE CORP (TWST) has a market capitalization of 1.54B USD. This makes TWST a Small Cap stock.


How many employees does TWIST BIOSCIENCE CORP have?

TWIST BIOSCIENCE CORP (TWST) currently has 923 employees.


What are the support and resistance levels for TWIST BIOSCIENCE CORP (TWST) stock?

TWIST BIOSCIENCE CORP (TWST) has a resistance level at 34.74. Check the full technical report for a detailed analysis of TWST support and resistance levels.


Is TWIST BIOSCIENCE CORP (TWST) expected to grow?

The Revenue of TWIST BIOSCIENCE CORP (TWST) is expected to grow by 21.2% in the next year. Check the estimates tab for more information on the TWST EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy TWIST BIOSCIENCE CORP (TWST) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TWIST BIOSCIENCE CORP (TWST) stock pay dividends?

TWST does not pay a dividend.


When does TWIST BIOSCIENCE CORP (TWST) report earnings?

TWIST BIOSCIENCE CORP (TWST) will report earnings on 2025-11-17, after the market close.


What is the Price/Earnings (PE) ratio of TWIST BIOSCIENCE CORP (TWST)?

TWIST BIOSCIENCE CORP (TWST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.25).


What is the Short Interest ratio of TWIST BIOSCIENCE CORP (TWST) stock?

The outstanding short interest for TWIST BIOSCIENCE CORP (TWST) is 18.3% of its float. Check the ownership tab for more information on the TWST short interest.


TWST Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TWST Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to TWST. While TWST has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TWST Financial Highlights

Over the last trailing twelve months TWST reported a non-GAAP Earnings per Share(EPS) of -2.25. The EPS increased by 41.1% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -32.09%
ROE -43.43%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%68.03%
Sales Q2Q%17.92%
EPS 1Y (TTM)41.1%
Revenue 1Y (TTM)27.69%

TWST Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 81% to TWST. The Buy consensus is the average rating of analysts ratings from 18 analysts.

For the next year, analysts expect an EPS growth of 38.36% and a revenue growth 21.2% for TWST


Ownership
Inst Owners115.24%
Ins Owners1.35%
Short Float %18.3%
Short Ratio10.25
Analysts
Analysts81.11
Price Target48.77 (90.21%)
EPS Next Y38.36%
Revenue Next Year21.2%